vs
REPLIGEN CORP（RGEN）与GIBRALTAR INDUSTRIES, INC.（ROCK）财务数据对比。点击上方公司名可切换其他公司
GIBRALTAR INDUSTRIES, INC.的季度营收约是REPLIGEN CORP的1.1倍（$225.0M vs $197.9M），GIBRALTAR INDUSTRIES, INC.同比增速更快（24.9% vs 13.6%），GIBRALTAR INDUSTRIES, INC.自由现金流更多（$26.2M vs $17.6M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs -12.3%）
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
直布罗陀工业公司是专业建筑、基础设施及可再生能源产品制造商与分销商，主营通风系统、屋面配件、太阳能安装支架、园林景观产品等，主要服务北美地区住宅、商业建筑及清洁能源市场，专注提供创新可持续的客户解决方案。
RGEN vs ROCK — 直观对比
营收规模更大
ROCK
是对方的1.1倍
$197.9M
营收增速更快
ROCK
高出11.3%
13.6%
自由现金流更多
ROCK
多$8.7M
$17.6M
两年增速更快
RGEN
近两年复合增速
-12.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $197.9M | $225.0M |
| 净利润 | $13.3M | — |
| 毛利率 | 52.5% | 25.3% |
| 营业利润率 | 9.0% | 7.9% |
| 净利率 | 6.7% | — |
| 营收同比 | 13.6% | 24.9% |
| 净利润同比 | 143.9% | — |
| 每股收益（稀释后） | $0.24 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RGENROCK
| Q4 25 | $197.9M | $225.0M | ||
| Q3 25 | $188.8M | $310.9M | ||
| Q2 25 | $182.4M | $309.5M | ||
| Q1 25 | $169.2M | $290.0M | ||
| Q4 24 | $174.1M | $180.1M | ||
| Q3 24 | $154.9M | $277.1M | ||
| Q2 24 | $154.1M | $273.6M | ||
| Q1 24 | $151.3M | $292.5M |
净利润RGENROCK
| Q4 25 | $13.3M | — | ||
| Q3 25 | $14.9M | $-89.1M | ||
| Q2 25 | $14.9M | $26.0M | ||
| Q1 25 | $5.8M | $21.1M | ||
| Q4 24 | $-30.3M | — | ||
| Q3 24 | $-654.0K | $34.0M | ||
| Q2 24 | $3.3M | $32.2M | ||
| Q1 24 | $2.1M | $24.9M |
毛利率RGENROCK
| Q4 25 | 52.5% | 25.3% | ||
| Q3 25 | 53.2% | 26.6% | ||
| Q2 25 | 50.0% | 28.4% | ||
| Q1 25 | 53.6% | 26.8% | ||
| Q4 24 | 26.1% | 29.0% | ||
| Q3 24 | 50.0% | 29.4% | ||
| Q2 24 | 49.8% | 30.5% | ||
| Q1 24 | 49.5% | 28.9% |
营业利润率RGENROCK
| Q4 25 | 9.0% | 7.9% | ||
| Q3 25 | 8.9% | 12.8% | ||
| Q2 25 | 7.6% | 12.8% | ||
| Q1 25 | 3.9% | 8.8% | ||
| Q4 24 | -17.7% | 13.3% | ||
| Q3 24 | -5.1% | 15.6% | ||
| Q2 24 | 1.0% | 14.9% | ||
| Q1 24 | 1.3% | 10.8% |
净利率RGENROCK
| Q4 25 | 6.7% | — | ||
| Q3 25 | 7.9% | -28.6% | ||
| Q2 25 | 8.2% | 8.4% | ||
| Q1 25 | 3.4% | 7.3% | ||
| Q4 24 | -17.4% | — | ||
| Q3 24 | -0.4% | 12.3% | ||
| Q2 24 | 2.2% | 11.8% | ||
| Q1 24 | 1.4% | 8.5% |
每股收益（稀释后）RGENROCK
| Q4 25 | $0.24 | — | ||
| Q3 25 | $0.26 | $-2.98 | ||
| Q2 25 | $0.26 | $0.87 | ||
| Q1 25 | $0.10 | — | ||
| Q4 24 | $-0.55 | — | ||
| Q3 24 | $-0.01 | $1.11 | ||
| Q2 24 | $0.06 | $1.05 | ||
| Q1 24 | $0.04 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $767.6M | $115.7M |
| 总债务越低越好 | $542.2M | $0 |
| 股东权益账面价值 | $2.1B | $950.4M |
| 总资产 | $2.9B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.26× | 0.00× |
8季度趋势，按日历期对齐
现金及短期投资RGENROCK
| Q4 25 | $767.6M | $115.7M | ||
| Q3 25 | $748.7M | $89.4M | ||
| Q2 25 | $708.9M | $43.3M | ||
| Q1 25 | $697.2M | $25.1M | ||
| Q4 24 | $757.4M | $269.5M | ||
| Q3 24 | $784.0M | $228.9M | ||
| Q2 24 | $809.1M | $179.1M | ||
| Q1 24 | $780.6M | $146.7M |
总债务RGENROCK
| Q4 25 | $542.2M | $0 | ||
| Q3 25 | $537.9M | $0 | ||
| Q2 25 | — | $0 | ||
| Q1 25 | — | $0 | ||
| Q4 24 | $525.6M | $0 | ||
| Q3 24 | — | $0 | ||
| Q2 24 | — | $0 | ||
| Q1 24 | — | $0 |
股东权益RGENROCK
| Q4 25 | $2.1B | $950.4M | ||
| Q3 25 | $2.1B | $951.8M | ||
| Q2 25 | $2.1B | $1.0B | ||
| Q1 25 | $2.0B | $1.0B | ||
| Q4 24 | $2.0B | $1.0B | ||
| Q3 24 | $2.0B | $1.0B | ||
| Q2 24 | $2.0B | $975.7M | ||
| Q1 24 | $2.0B | $940.2M |
总资产RGENROCK
| Q4 25 | $2.9B | $1.4B | ||
| Q3 25 | $2.9B | $1.4B | ||
| Q2 25 | $2.9B | $1.5B | ||
| Q1 25 | $2.9B | $1.4B | ||
| Q4 24 | $2.8B | $1.4B | ||
| Q3 24 | $2.8B | $1.4B | ||
| Q2 24 | $2.9B | $1.4B | ||
| Q1 24 | $2.8B | $1.3B |
负债/权益比RGENROCK
| Q4 25 | 0.26× | 0.00× | ||
| Q3 25 | 0.26× | 0.00× | ||
| Q2 25 | — | 0.00× | ||
| Q1 25 | — | 0.00× | ||
| Q4 24 | 0.27× | 0.00× | ||
| Q3 24 | — | 0.00× | ||
| Q2 24 | — | 0.00× | ||
| Q1 24 | — | 0.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.7M | $35.5M |
| 自由现金流经营现金流 - 资本支出 | $17.6M | $26.2M |
| 自由现金流率自由现金流/营收 | 8.9% | 11.7% |
| 资本支出强度资本支出/营收 | 4.1% | 4.1% |
| 现金转化率经营现金流/净利润 | 1.93× | — |
| 过去12个月自由现金流最近4个季度 | $93.9M | $120.6M |
8季度趋势，按日历期对齐
经营现金流RGENROCK
| Q4 25 | $25.7M | $35.5M | ||
| Q3 25 | $48.1M | $73.0M | ||
| Q2 25 | $28.6M | $44.9M | ||
| Q1 25 | $15.0M | $13.7M | ||
| Q4 24 | $39.2M | $19.9M | ||
| Q3 24 | $49.3M | $64.7M | ||
| Q2 24 | $42.2M | $36.5M | ||
| Q1 24 | $44.7M | $53.2M |
自由现金流RGENROCK
| Q4 25 | $17.6M | $26.2M | ||
| Q3 25 | $43.4M | $64.8M | ||
| Q2 25 | $21.5M | $27.3M | ||
| Q1 25 | $11.4M | $2.3M | ||
| Q4 24 | $33.6M | $14.1M | ||
| Q3 24 | $42.3M | $60.5M | ||
| Q2 24 | $37.4M | $33.5M | ||
| Q1 24 | $36.4M | $48.8M |
自由现金流率RGENROCK
| Q4 25 | 8.9% | 11.7% | ||
| Q3 25 | 23.0% | 20.8% | ||
| Q2 25 | 11.8% | 8.8% | ||
| Q1 25 | 6.8% | 0.8% | ||
| Q4 24 | 19.3% | 7.8% | ||
| Q3 24 | 27.3% | 21.8% | ||
| Q2 24 | 24.3% | 12.2% | ||
| Q1 24 | 24.0% | 16.7% |
资本支出强度RGENROCK
| Q4 25 | 4.1% | 4.1% | ||
| Q3 25 | 2.5% | 2.6% | ||
| Q2 25 | 3.9% | 5.7% | ||
| Q1 25 | 2.1% | 3.9% | ||
| Q4 24 | 3.2% | 3.3% | ||
| Q3 24 | 4.5% | 1.5% | ||
| Q2 24 | 3.1% | 1.1% | ||
| Q1 24 | 5.5% | 1.5% |
现金转化率RGENROCK
| Q4 25 | 1.93× | — | ||
| Q3 25 | 3.23× | — | ||
| Q2 25 | 1.92× | 1.73× | ||
| Q1 25 | 2.57× | 0.65× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.90× | ||
| Q2 24 | 12.70× | 1.13× | ||
| Q1 24 | 21.35× | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RGEN
暂无分部数据
ROCK
| Transferred At Point In Time | $183.5M | 82% |
| Infrastructure | $22.5M | 10% |
| Other | $18.9M | 8% |
